Cabaletta Bio, Inc. — Director's Dealing 2020

Sep 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2020-09-14

Reporting Person: Stalter John Brian (General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-14	Stock Option (Right to Buy)	$12.01	A	60000	Acquired	2030-09-13	Common Stock (60000)	Direct

Footnotes

F1: This option vests over four years, with 25% vesting on September 14, 2021, and the remaining shares vesting in 12 equal quarterly installments thereafter.